Brief: Oncolytics Biotech Announces New US Patent For Pelareorep Manufacturing Process
16/06/2026 14:27
BRIEF-Oncolytics Biotech Announces New US Patent For Pelareorep Manufacturing Process June 16 (Reuters) - Oncolytics Biotech Inc ONCY.O:
ONCOLYTICS BIOTECH - ANNOUNCES NEW U.S. PATENT FOR PELAREOREP MANUFACTURING PROCESS
ONCOLYTICS BIOTECH - NEW PATENT PROVIDES PELAREOREP MANUFACTURING PROTECTION INTO 2044
Source text: ID:nGNX7bHfpf
Further company coverage: ONCY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Expects Final Cohort 4 Results Of Goblet Study In Q4 2026
Brief: Oncolytics Biotech® Secures Patent Protection To Late 2040S And Provides Intellectual Property Portfolio Update
Brief: Oncolytics Biotech® Aligns With FDA On Registrational Path For Second-Line Ras-Mutant Mss Colorectal Cancer
Brief: Oncolytics Biotech Announces New US Patent For Pelareorep Manufacturing Process
Brief: Oncolytics Biotech® Reports Durable Responses In Second-Line Ras-Mutant Mss Colorectal Cancer